| Name | Title | Contact Details |
|---|
Creative Consulting is a Phoenix, AZ-based company in the Business Services sector.
Our Vision We believe that universal access to space will inherently improve human life. Our Mission Empower humans to connect and progress through space technology. What We Do We provide exceptional NanoSats and space services to business, exploration, and science teams. The Way Forward EnduroSats Shared Satellite Service enables continuous improvement in space operations at a fraction of the cost. Our goal is to provide easy access to space for visionary entrepreneurs, scientists, and technologists, helping them drive innovation in the final frontier. EnduroSats software-defined NanoSats enable plug-and-play payload integration and open unique capabilities to fly fast and improve your technology in space.
Magna Publications Inc is a Madison, WI-based company in the Business Services sector.
C.A. Walker Research Solutions is a Glendale, CA-based company in the Business Services sector.
Petauri is a pharmaceutical services platform founded in 2023 and based in Nashville, Tennessee. The company focuses on providing integrated commercialization solutions for life sciences companies throughout the therapeutic lifecycle. Led by CEO Dan Renick, who has over 30 years of experience in the healthcare industry, Petauri aims to enhance clinical and economic value while accelerating the delivery of treatments to patients with unmet medical needs. The company offers a comprehensive range of services, including insights generation, medical and scientific communications, market access, and evidence-based solutions. Its U.S. Market Access activities are divided into three business units: Petauri Advisors, which provides pricing and market access consultancy; Petauri MAx, a strategic payer marketing agency; and Petauri Kinect, which focuses on engagement with health systems and hospitals. Petauri serves pharmaceutical and life sciences clients globally, helping them navigate complex healthcare ecosystems and optimize patient access to innovative therapies.